Moneycontrol
HomeNewsWorldNgozi Okonjo-Iweala: Nigeria's hope to head the WTO
Trending Topics

Ngozi Okonjo-Iweala: Nigeria's hope to head the WTO

The 66-year-old is looking to make more history as she bids to become the first African and woman to head the World Trade Organization (WTO).

February 06, 2021 / 15:17 IST
Story continues below Advertisement
A picture taken on July 15, 2020, in Geneva shows Nigerian former Foreign and Finance Minister Ngozi Okonjo-Iweala smiling during a hearing before World Trade Organization 164 member states' representatives, as part of the application process to head the WTO as Director General. (PC-AFP)

Twice Nigeria's finance minister and its first woman foreign minister, Ngozi Okonjo-Iweala has been described as a trailblazer.

Now the 66-year-old is looking to make more history as she bids to become the first African and woman to head the World Trade Organization (WTO).

Story continues below Advertisement

Aside from her time in public office, the development economist had a quarter-century at the World Bank -- rising to be managing director and running for the top role in 2012.

China raises 'deep concerns' at WTO meet over India’s FDI scrutiny: Report

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show